Last updated on September 2019

I5T-MC-AACG TRAILBLAZER-ALZ Assessment of Safety, Tolerability and Efficacy of LY3002813 Alone and in Combination With LY3202626 in Early Symptomatic Alzheimer’s Disease


Brief description of study

This is a study for early to mild Alzheimer’s, testing the safety of LY3002813 with or without LY3202626 and any side effects from the study medicine.

This study is also evaluating whether LY3002813 with or without LY3202626 can help slow the mental and functional changes of Alzheimer’s disease.

 

Clinical Study Identifier: TX207242

Find a site near you

Start Over

Pharmacology Research Institute, Newport Beach

1601 Dove Street, Suite 290 Newport Beach, CA United States
  Connect »